Canada markets open in 2 hours 14 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
13.86-0.20 (-1.42%)
At close: 04:00PM EDT
13.75 -0.11 (-0.79%)
After hours: 05:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 43.41B
Enterprise Value 69.10B
Trailing P/E 26.06
Forward P/E 9.83
PEG Ratio (5 yr expected) 0.50
Price/Sales (ttm)1.68
Price/Book (mrq)1.04
Enterprise Value/Revenue 0.02
Enterprise Value/EBITDA 0.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-17.65%
S&P500 52-Week Change 3-11.08%
52 Week High 317.31
52 Week Low 313.05
50-Day Moving Average 314.18
200-Day Moving Average 314.51

Share Statistics

Avg Vol (3 month) 32.69M
Avg Vol (10 day) 33.26M
Shares Outstanding 53.11B
Implied Shares Outstanding 6N/A
Float 83.06B
% Held by Insiders 10.01%
% Held by Institutions 11.86%
Shares Short (Jun 14, 2022) 44.06M
Short Ratio (Jun 14, 2022) 41.5
Short % of Float (Jun 14, 2022) 4N/A
Short % of Shares Outstanding (Jun 14, 2022) 40.13%
Shares Short (prior month May 12, 2022) 45.3M

Dividends & Splits

Forward Annual Dividend Rate 40.8
Forward Annual Dividend Yield 45.71%
Trailing Annual Dividend Rate 3180.00
Trailing Annual Dividend Yield 31,280.23%
5 Year Average Dividend Yield 44.36
Payout Ratio 460.92%
Dividend Date 3Dec 14, 2009
Ex-Dividend Date 4Sept 28, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 30, 2022
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 6.45%
Operating Margin (ttm)24.34%

Management Effectiveness

Return on Assets (ttm)4.16%
Return on Equity (ttm)4.24%

Income Statement

Revenue (ttm)3.57T
Revenue Per Share (ttm)1,141.35
Quarterly Revenue Growth (yoy)13.40%
Gross Profit (ttm)2.46T
EBITDA 1.45T
Net Income Avi to Common (ttm)230.06B
Diluted EPS (ttm)0.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)849.7B
Total Cash Per Share (mrq)274.03
Total Debt (mrq)4.35T
Total Debt/Equity (mrq)76.46
Current Ratio (mrq)1.21
Book Value Per Share (mrq)1,832.81

Cash Flow Statement

Operating Cash Flow (ttm)1.12T
Levered Free Cash Flow (ttm)1.12T